Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
2.700
-0.100 (-3.57%)
At close: Oct 26, 2026, 4:00 PM EDT
2.700
0.00 (0.00%)
After-hours: Oct 26, 2026, 4:00 PM EDT
Lexeo Therapeutics Market Cap
Lexeo Therapeutics has a market cap or net worth of $221.51 million as of October 26, 2026. It is the 19,811th most valuable company in the world and the 3,453rd biggest in the United States. Its market cap has decreased by 65.53% in one year.
Market Cap
221.51M
Enterprise Value
16.62M
1-Year Change
-65.53%
Global Rank
Country Rank
#3,453 United States
Category
ChartMarket Cap Chart
Since the IPO on November 3, 2023, Lexeo Therapeutics's market cap has decreased from $271.36M to $221.51M, a decrease of -18.37%. That is a compound annual growth rate of -6.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 221.51M | -69.44% |
| Dec 31, 2025 | 724.76M | 232.99% |
| Dec 31, 2024 | 217.65M | -39.13% |
| Dec 29, 2023 | 357.58M | 31.78% |
| Nov 3, 2023 | 271.36M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Larimar Therapeutics | 245.30M |
| Vanda Pharmaceuticals | 242.46M |
| Immuneering | 241.32M |
| AC Immune | 240.61M |
| Greenwich LifeSciences | 235.29M |
| Palisade Bio | 231.78M |
| Lyell Immunopharma | 230.10M |
| InflaRx | 229.89M |